Nixon RA

Title : Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration - Jiang_2022_Nat.Commun_13_5308

Author(s) : Jiang Y , Alam JJ , Gomperts SN , Maruff P , Lemstra AW , Germann UA , Stavrides PH , Darji S , Malampati S , Peddy J , Bleiwas C , Pawlik M , Pensalfini A , Yang DS , Subbanna S , Basavarajappa BS , Smiley JF , Gardner A , Blackburn K , Chu HM , Prins ND , Teunissen CE , Harrison JE , Scheltens P , Nixon RA

Ref : Nat Commun , 13 :5308 , 2022

Abstract :

PubMedSearch : Jiang_2022_Nat.Commun_13_5308

PubMedID: 36130946

Title : In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model - Chen_2009_Neurobiol.Aging_30_1453

Author(s) : Chen Y , Dyakin VV , Branch CA , Ardekani B , Yang D , Guilfoyle DN , Peterson J , Peterhoff C , Ginsberg SD , Cataldo AM , Nixon RA

Ref : Neurobiology of Aging , 30 :1453 , 2009

Abstract :

PubMedSearch : Chen_2009_Neurobiol.Aging_30_1453

PubMedID: 18180075

Nixon RA

References (2)

1. Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration - Jiang_2022_Nat.Commun_13_5308

2. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model - Chen_2009_Neurobiol.Aging_30_1453